Skip to main content

Anixa Biosciences Inc

ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000715446

In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Anixa Biosciences Inc changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of ANIX: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders6671+5
Shares5.41M5.66M+241.8K (+4.5%)
Value$17.9M$17.6M−$229.7K (−1.3%)

New holders (13)

Institutions that held Anixa Biosciences Inc at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to ANIX in Q4 2025
InstitutionSharesValue% of portfolio
683 Capital Management, LLC113,636$354.5K0.03%
ExodusPoint Capital Management, LP93,931$293.1K0.00%
Qube Research & Technologies Ltd59,519$185.7K0.00%
Virtu Financial LLC51,759$161.0K0.01%
Point72 Asset Management, L.P.31,056$96.9K0.00%
Omers Administration Corp30,500$95.2K0.00%
Squarepoint Ops LLC26,676$83.2K0.00%
Graham Capital Management, L.P.26,082$81.4K0.00%
Lighthouse Investment Partners, LLC16,980$53.0K0.00%
Millennium Management LLC12,177$38.0K0.00%
Cetera Investment Advisers11,127$34.7K0.00%
BNP Paribas Arbitrage, SA9,140$28.5K0.00%
Canada Pension Plan Investment Board7,500$23.4K0.00%

Sold out (8)

Institutions that held Anixa Biosciences Inc at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of ANIX in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Prosperity Wealth Management, Inc.41,800$137.9K
Group One Trading, L.P.4,832$15.9K
Principal Securities, Inc.1,000$3.30K
Crowley Wealth Management, Inc.1,000$3.30K
Park Circle Co500$1.65K
Advisory Services Network, LLC400$1.32K
Barclays PLC9$30
Citigroup Inc1$3